Alex Mabry

Program: Cancer Biology

Current advisor: Jason D. Weber, PhD

Undergraduate university: Indiana University-Bloomington, 2018

Enrollment year: 2021

Research summary
Therapeutic targeting of type I interferon signaling in CDK4/6i resistant ER+/HER2- breast cancer

Graduate publications
Mabry A, Kuzmicki CE, O’Brien A, Maggi LB Jr, Weber JD. 2025 Elevated Type I Interferon Signaling Defines the Proliferative Advantage of ARF and p53 Mutant Tumor Cells. Mol Cell Biol, 45(6):246-61. PMCID: PMC12136988

Panikar SS, Keltee N, Berry NK, Shmuel S, Fisher ZT, Brown E, Zidel A, Mabry A, Pereira PMR. 2023 Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors. J Nucl Med, 64(8):1195-202. PMCID: PMC10394312